or Try an Advanced Search...

    Technical Analysis for VINC - Vincera Pharma, Inc.

    Grade Last Price % Change Price Change
    D 0.76 -6.26% -0.05
    VINC closed down 6.26 percent on Monday, July 1, 2024, on 1.15 times normal volume. It was able to find support at its 50 day moving average. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Up Up
    Historical VINC trend table...
    Date Alert Name Type % Chg
    50 DMA Support Bullish 0.00%
    Stochastic Reached Overbought Strength 0.00%
    Upper Bollinger Band Walk Strength 0.00%
    Weak + Overbought Other 0.00%
    Wide Bands Range Expansion 0.00%
    Overbought Stochastic Strength 0.00%
    Upper Bollinger Band Touch Strength 0.00%
    20 DMA Support Bullish -6.26%
    Crossed Above 50 DMA Bullish -6.26%
    New Uptrend Bullish -6.26%
    Older End-of-Day Signals for VINC ...

       Recent Intraday Alerts

    Alert Time
    Fell Below 50 DMA about 6 hours ago
    50 DMA Support about 6 hours ago
    Down 5% about 6 hours ago
    Down 10% about 6 hours ago
    Down 1 ATR about 6 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    VINC Chart by TradingView
    Basic chart:

    Profile

    Vincera Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops new therapies to address unmet medical needs for the treatment of cancer. The company's lead product candidate is VIP152 that is in clinical trials. Its drug candidates are in development for the treatment of solid tumors, leukemia, B-cell malignancies, lymphomas, and myelodysplastic syndrome. Vincera Pharma, Inc. is based in Santa Clara, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biopharmaceutical Cancer Clinical Medicine Solid Tumors Treatment Of Cancer Lymphoma Hematology Leukemia Myelodysplastic Syndrome Anatomical Pathology

    Is VINC a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 27 Vincerx Pharma (VINC) Moves to Buy: Rationale Behind the Upgrade
    May 15 Vincerx Pharma GAAP EPS of -$0.58
    May 14 Vincerx Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
    Apr 26 Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Apr 26 Vincerx Pharma dips 16%, prices $16M stock
    Apr 26 Vincerx Pharma Announces Pricing of Underwritten Public Offering of Common Stock and Warrants
    Apr 25 Vincerx Pharma announces proposed underwritten public offering of common stock and warrants
    Apr 25 Vincerx Pharma Announces Proposed Underwritten Public Offering of Common Stock and Warrants
    Apr 9 Vincerx (VINC) Tumbles on Results From Cancer Therapy Study
    Apr 9 Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    See more VINC news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 9.3722
    52 Week Low 0.5684
    Average Volume 306,863
    200-Day Moving Average 1.68
    50-Day Moving Average 0.74
    20-Day Moving Average 0.67
    10-Day Moving Average 0.65
    Average True Range 0.09
    RSI (14) 50.25
    ADX 31.13
    +DI 26.54
    -DI 19.42
    Chandelier Exit (Long, 3 ATRs) 0.58
    Chandelier Exit (Short, 3 ATRs) 0.84
    Upper Bollinger Bands 0.81
    Lower Bollinger Band 0.54
    Percent B (%b) 0.81
    BandWidth 39.93
    MACD Line -0.06
    MACD Signal Line -0.10
    MACD Histogram 0.0432
    Fundamentals Value
    Market Cap 16.23 Million
    Num Shares 21.4 Million
    EPS -2.31
    Price-to-Earnings (P/E) Ratio -0.33
    Price-to-Sales 0.00
    Price-to-Book 1.83
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.98
    Resistance 3 (R3) 0.99 0.93 0.95
    Resistance 2 (R2) 0.93 0.87 0.92 0.93
    Resistance 1 (R1) 0.84 0.83 0.81 0.83 0.92
    Pivot Point 0.78 0.78 0.76 0.77 0.78
    Support 1 (S1) 0.69 0.72 0.66 0.68 0.60
    Support 2 (S2) 0.63 0.68 0.62 0.58
    Support 3 (S3) 0.54 0.63 0.57
    Support 4 (S4) 0.54